CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Author:

Hu Shimin1,Xu-Monette Zijun Y.1,Balasubramanyam Aarthi2,Manyam Ganiraju C.3,Visco Carlo4,Tzankov Alexander5,Liu Wei-min2,Miranda Roberto N.1,Zhang Li3,Montes-Moreno Santiago6,Dybkær Karen7,Chiu April8,Orazi Attilio9,Zu Youli10,Bhagat Govind11,Richards Kristy L.12,Hsi Eric D.13,Choi William W. L.14,Han van Krieken J.15,Huang Qin16,Huh Jooryung17,Ai Weiyun18,Ponzoni Maurilio19,Ferreri Andrés J. M.19,Zhao Xiaoying20,Winter Jane N.21,Zhang Mingzhi22,Li Ling22,Møller Michael B.23,Piris Miguel A.6,Li Yong24,Go Ronald S.25,Wu Lin2,Medeiros L. Jeffrey1,Young Ken H.1

Affiliation:

1. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX;

2. Roche Molecular Systems Inc., Pleasanton, CA;

3. Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX;

4. San Bortolo Hospital, Vicenza, Italy;

5. University Hospital, Basel, Switzerland;

6. Hospital Universitario Marques de Valdecilla, Santander, Spain;

7. Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark;

8. Memorial Sloan-Kettering Cancer Center, New York, NY;

9. Weill Medical College of Cornell University, New York, NY;

10. The Methodist Hospital, Houston, TX;

11. Columbia University Medical Center and New York Presbyterian Hospital, New York, NY;

12. University of North Carolina School of Medicine, Chapel Hill, NC;

13. Cleveland Clinic, Cleveland, OH;

14. University of Hong Kong Li Ka Shing Faculty of Medicine, Hong Kong, China;

15. Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands;

16. City of Hope National Medical Center, Duarte, CA;

17. Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea;

18. University of California San Francisco School of Medicine, San Francisco, CA;

19. San Raffaele H. Scientific Institute, Milan, Italy;

20. Zhejiang University School of Medicine, Second University Hospital, Hangzhou, China;

21. Feinberg School of Medicine, Northwestern University, Chicago, IL;

22. Zhengzhou University Medical Center, Zhengzhou, China;

23. Odense University Hospital, Odense, Denmark;

24. University of Louisville, Louisville, KY; and

25. Gundersen Lutheran Health System, La Crosse, WI

Abstract

Key Points CD30 expression defines a novel and unique subgroup of DLBCL with favorable clinical outcome and distinct gene expression signature.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 207 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy;Biochemical Pharmacology;2024-09

2. SATB1 and p16 Expression and Prognostic Value in Croatian Hodgkin Lymphoma Patients: A Unicentric Study;Cells;2024-08-08

3. Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas;Cancers;2024-06-17

4. Clinicopathologic features and survival outcomes of CD30 expression in extranodal natural killer/T-cell lymphoma;American Journal of Clinical Pathology;2024-02-22

5. Targeting CD 30 in Lymphoid Neoplasms;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3